Examples of using Bleeding episodes in English and their translations into German
{-}
-
Colloquial
-
Official
-
Ecclesiastic
-
Medicine
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Control and Prevention of Bleeding Episodes.
Of the 26 bleeding episodes, 15 were minor, 9 moderate, and 2 major.
Table 1: Guide for dosing in bleeding episodes and surgery.
Of the 249 bleeding episodes, the majority(211; 84.7%) were treated with 1-2 infusions.
Table 1 Guide for dosing in bleeding episodes and surgery.
Four bleeding episodes in two subjects were considered treatment failures.
An additional 14 PTPs received RIXUBIS for the treatment of bleeding episodes only.
Treatment of bleeding episodes in patients with acquired haemophilia caused by antibodies to Factor VIII.
Table 1 can be used to guide dosing in bleeding episodes and surgery.
Mild bleeding episodes with pain that arise due to puncture of a cyst are usually treated with analgesics.
Table 1: Guide to ELOCTA dosing for treatment of bleeding episodes and surgery.
During the long-term study, no bleeding episodes were observed in children below 6 years of age treated with NovoThirteen.
In the first study, involving 73 patients aged 12 to 59 years,249 bleeding episodes were treated with Rixubis.
For treatment of bleeding episodes: 25 IU/kg Coagadex should be injected when the first sign of bleeding occurs or just before the expected onset of menstrual bleeding.
FVIII replacement prophylactic treatment reduces the number of bleeding episodes and the risk of permanent joint damage.
Two main studies of Eloctashowed that the medicine is effective at both preventing and treating bleeding episodes.
Coagadex is indicated for the treatment and prophylaxis of bleeding episodes and for perioperative management in patients with hereditary factor X deficiency.
If INR is not properly monitored and increased exposure to vitamin K antagonists remains undetected,severe or life-threatening bleeding episodes may occur.
No treatment requiring bleeding episodes have been detected in patients below 6 years during 8.7 years of cumulative follow-up, representing a total of 116 doses.
The results of the main study showed that Obizur was effective in treating serious bleeding episodes in adults with the disorder.
OBIZUR is used for the treatment of bleeding episodes in adults with acquired haemophilia a bleeding disorder caused by lack of Factor VIII activity due to antibody development.
BeneFIX has been studied in previously treated patients with moderate or severe haemophilia Bfor prevention or to treat bleeding episodes during and after surgery.
The benefits of Voncento in preventing and treating bleeding episodes in haemophilia A were shown in a study of 81 patients who had previously been treated with human coagulation factor VIII.
It is a coagulation factor IX(recombinant) indicated in adults and children≥ 12 years of age with hemophilia B for control andprevention of bleeding episodes, and for perioperative management.
Obizur is a medicine used for the treatment of bleeding episodes in adults with acquired haemophilia, a bleeding disorder caused by the spontaneous development of antibodies that inactivate factor VIII.
The efficacy of IDELVION has been evaluated in a phase 3 study, in which a total of 27 male PTPs between 1 and 10 years(median age 6.0 years) with 12 patients< 6 years,received IDELVION for prophylaxis and control of bleeding episodes.
Treatment of bleeding episodes: Of the 60 bleeding events observed during study II, 75% were controlled with 1 injection, and overall 91.7% of bleeding episodes were controlled with 2 or fewer injections.
In the second study in 30 children aged below 12 years, Alprolix was similarly effective:2 bleeding episodes occurred per year on average and around 75% of bleeding episodes resolved with one injection.
In a multicentre, open-label, non-randomised clinical trial to evaluate the pharmacokinetics, safety and efficacy of Coagadex, 16 subjects(aged 12 years and above) with moderate to severe hereditary factor X deficiency(FX:C< 5 IU/dL) received a dose of 25 IU/kg Coagadex to treat spontaneous,traumatic and menorrhagic bleeding episodes.
In the first study involving 123 adults and adolescents aged 12 years or above,patients given Alprolix as a weekly preventive treatment had around 3 bleeding episodes a year, patients given Alprolix as an every 10 days preventive treatment had around 2 bleeding episodes per year, and patients given Alprolix for treating bleedings on demand had around 18 bleeding episodes a year.